======= RC3H2 ======= == Gene Information == * **Official Symbol**: RC3H2 * **Official Name**: ring finger and CCCH-type domains 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54542|54542]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HBD1|Q9HBD1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RC3H2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RC3H2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615231|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |zf-CCCH| |T follicular helper cell differentiation| |negative regulation of T-helper 17 cell differentiation| |regulation of miRNA metabolic process| |negative regulation of T-helper 17 type immune response| |negative regulation of T-helper cell differentiation| |regulation of T-helper 17 cell differentiation| |lymph node development| |negative regulation of CD4-positive, alpha-beta T cell differentiation| |regulation of T-helper 17 type immune response| |RNA stem-loop binding| |negative regulation of alpha-beta T cell differentiation| |B cell homeostasis| |CD4-positive, alpha-beta T cell differentiation involved in immune response| |T-helper cell differentiation| |alpha-beta T cell activation involved in immune response| |alpha-beta T cell differentiation involved in immune response| |negative regulation of CD4-positive, alpha-beta T cell activation| |T cell differentiation involved in immune response| |spleen development| |T cell homeostasis| |CD4-positive, alpha-beta T cell differentiation| |regulation of T-helper cell differentiation| |T cell proliferation| |negative regulation of alpha-beta T cell activation| |CD4-positive, alpha-beta T cell activation| |negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |lung alveolus development| |negative regulation of T cell differentiation| |negative regulation of adaptive immune response| |regulation of CD4-positive, alpha-beta T cell differentiation| |alpha-beta T cell differentiation| |lymphocyte homeostasis| |negative regulation of lymphocyte differentiation| |regulation of CD4-positive, alpha-beta T cell activation| |alpha-beta T cell activation| |regulation of alpha-beta T cell differentiation| |T cell activation involved in immune response| |leukocyte homeostasis| |double-stranded RNA binding| |positive regulation of NIK/NF-kappaB signaling| |multicellular organism growth| |lymphocyte proliferation| |P-body| |mononuclear cell proliferation| |post-embryonic development| |regulation of alpha-beta T cell activation| |leukocyte proliferation| |negative regulation of leukocyte differentiation| |regulation of NIK/NF-kappaB signaling| |negative regulation of T cell activation| |lymphocyte activation involved in immune response| |negative regulation of immune effector process| |negative regulation of leukocyte cell-cell adhesion| |T cell differentiation| |negative regulation of hemopoiesis| |regulation of T cell differentiation| |regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |negative regulation of lymphocyte activation| |negative regulation of immune response| |regulation of adaptive immune response| |mRNA binding| |regulation of lymphocyte differentiation| |lung development| |respiratory tube development| |negative regulation of leukocyte activation| |negative regulation of cell-cell adhesion| |T cell receptor signaling pathway| |limb development| |appendage development| |respiratory system development| |negative regulation of cell activation| |homeostasis of number of cells| |T cell activation| |lymphocyte differentiation| |ubiquitin-protein transferase activity| |negative regulation of cell adhesion| |regulation of leukocyte differentiation| |antigen receptor-mediated signaling pathway| |regulation of leukocyte cell-cell adhesion| |protein polyubiquitination| |regulation of T cell activation| |leukocyte differentiation| |lymphocyte activation| |developmental growth| |growth| |regulation of cell-cell adhesion| |negative regulation of immune system process| |immune response-activating cell surface receptor signaling pathway| |regulation of hemopoiesis| |regulation of immune effector process| |immune response-regulating cell surface receptor signaling pathway| |regulation of lymphocyte activation| |posttranscriptional regulation of gene expression| |cell population proliferation| |hemopoiesis| |immune response-activating signal transduction| |immune response-regulating signaling pathway| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |cell surface| |leukocyte activation involved in immune response| |cell activation involved in immune response| |activation of immune response| |regulation of cell activation| |immune system development| |regulation of cell adhesion| |intracellular membrane-bounded organelle| |protein ubiquitination| |negative regulation of cell differentiation| |protein modification by small protein conjugation| |tube development| |positive regulation of immune response| |leukocyte activation| |negative regulation of developmental process| |protein modification by small protein conjugation or removal| |positive regulation of intracellular signal transduction| |cell activation| |immune effector process| |regulation of immune response| |positive regulation of immune system process| |negative regulation of multicellular organismal process| |RNA binding| |DNA binding| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of response to stimulus| |homeostatic process| |positive regulation of signal transduction| |regulation of immune system process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |immune response| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.75| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|1.94| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12468 * **Expression level (log2 read counts)**: 6.61 {{:chemogenomics:nalm6 dist.png?nolink |}}